US. Health officials said on Monday that, the first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle.
The US National Institutes of Health said in a statement;
The open-label trial will enrol 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks.
The first participant received the investigational vaccine today.
A group of 45 healthy volunteers will have the jab, at the Kaiser Permanente research facility, in Seattle.
The vaccine cannot cause Covid-19 but contains a harmless genetic code copied from the virus that causes the disease.
SEE HOW TO MAKE MONEY ON THIS PLATFORM>>[http://bit.ly/2PvYHfC]
Donate to support Freshreporters=>https://freshreporters.com/support
For publication of your news content, articles, videos or any other news worthy materials, please send a mail to thefreshrepo [email protected]
For Advert and other info, you can send a WhatsApp Message to +2347050565443
Join thousands of readers to receive daily Latest News: